作者: Elisa Visalli , Natascia Crispino , Rosario Foti
DOI: 10.1007/S12325-019-00901-0
关键词:
摘要: Psoriatic arthritis (PsA) is a lifelong disease associated with extra-articular manifestations and several comorbidities, as well reduced quality of life psychosocial burden. Diagnostic delay poorer outcomes, while short between symptom onset diagnosis linked preservation function. Overcoming the barriers to early PsA often difficult achieve in absence well-characterized markers and/or definitive screening procedure. Once made, approaches care may differ countries, but treat-to-target approach can be advocated, constant patient follow-up visits specialist monitoring treatment comorbidities. Adequately addressing all aspects help drive patient-centered encourage better adherence. Given mounting number therapeutic options complexity management PsA, optimally treated by multidisciplinary approach, collaborative rheumatologists dermatologists advocated. The need for reinforced consensus among experts. Patient satisfaction has emerged central indicator quality, must remain goal patients PsA. Definition minimum set standards will Optimal greater collaboration clinicians should always encouraged so that receive best possible care. Funding: Pfizer Italy.